{"title":"Effects of E2/ERβ on follicular granulosa cells and on AMH/Smad signalling in endometriosis.","authors":"Xueying Li, Chang Liu, Lukanxuan Wu, Yujing Li, Li Xiao, Wei Huang","doi":"10.1080/14647273.2026.2638250","DOIUrl":"10.1080/14647273.2026.2638250","url":null,"abstract":"<p><p>Patients with endometriosis have greater risk of infertility, which is associated with compromised ovarian function. Dysfunction in follicular granulosa cells and hyperactivation of oestrogen receptor beta (ERβ) are evident in endometriosis. It is also known that anti-Müllerian hormone (AMH)/Smad signalling pathway regulates ovarian activity. In this study, we aimed to explore effects of oestradiol (E2)/ERβ on follicular granulosa cells and on AMH/Smad signalling in endometriosis. The human ovarian granulosa cells were obtained from patients with tubal factor infertility and ovarian endometriosis, respectively, who underwent IVF/ICSI-ET using GnRH antagonist protocol in our hospital. A human ovarian granulosa tumour cell line (KGN) was cultured and subject to treatments with oestradiol and/or PHTPP (a selective ERβ antagonist). Cell viability, apoptosis, migration, and invasion were assessed. The mRNA and protein expressions were also investigated. It was found that AMH/Smad signalling pathway was suppressed in human ovarian granulosa cells in patients with ovarian endometriosis. Then, in KGN cells, E2 treatment (10<sup>-10 </sup> mol/L for 72 h) did not alter cell viability or apoptosis, but E2 decreased migration and invasion via ERβ. Further, E2 inhibited AMH/Smad signalling pathway via ERβ in KGN cells. Conversely, selective inhibition of ERβ could reverse these effects. In conclusion, activation of E2/ERβ compromised the function of follicular granulosa cells in endometriosis, which may be mediated by AMH/Smad signalling pathway.</p>","PeriodicalId":13006,"journal":{"name":"Human Fertility","volume":"29 1","pages":"2638250"},"PeriodicalIF":2.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147364995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Human FertilityPub Date : 2026-12-01Epub Date: 2026-10-15DOI: 10.1080/14647273.2026.2741543
Zhong Fei, Jialu Wu
{"title":"How years of schooling affect fertility intentions by delaying age at first marriage.","authors":"Zhong Fei, Jialu Wu","doi":"10.1080/14647273.2026.2741543","DOIUrl":"https://doi.org/10.1080/14647273.2026.2741543","url":null,"abstract":"<p><p>China's persistently low fertility is linked to educational expansion and delayed marriage. Using data from the Chinese General Social Survey (2015, 2017, 2018, and 2021, <i>N</i> = 6,310) of ever-married individuals aged 20-40 years, this study examines the direct and mediating effects of the number of years of schooling and age at first marriage on fertility intentions. The results indicate the following: (1) Years of schooling indirectly reduce fertility intentions by delaying first marriage, with a mediating effect of 38.5%, confirming an 'education→delayed marriage→lower fertility intentions' pathway. (2) The effect of delayed first marriage on fertility intentions is substantially greater than the independent effect of education. (3) Gender heterogeneity exists: for men, the effect of education is fully mediated by marriage timing, whereas for women, it is only partial. (4) Subgroup analyses reveal that the mediating pathway is more pronounced among agricultural hukou holders and medium-status families, and serial mediation further shows that delayed marriage lowers fertility intentions partly through matching with more educated spouses, accounting for an additional 23.1% of the total effect. We conclude that China's low-fertility crisis is a systemic outcome of educational expansion, marriage postponement, and conflicting policy goals, with marriage and assortative mating serving as key transmission channels.</p>","PeriodicalId":13006,"journal":{"name":"Human Fertility","volume":"29 1","pages":"2741543"},"PeriodicalIF":2.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149193145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Human FertilityPub Date : 2026-12-01Epub Date: 2026-10-27DOI: 10.1080/14647273.2026.2746891
Murong Xu, Carol Pui Shan Chan, Jacqueline Pui Wah Chung, David Yiu Leung Chan
{"title":"Evaluation of prolonged <i>in vitro</i> incubation of human sperm at room temperature.","authors":"Murong Xu, Carol Pui Shan Chan, Jacqueline Pui Wah Chung, David Yiu Leung Chan","doi":"10.1080/14647273.2026.2746891","DOIUrl":"https://doi.org/10.1080/14647273.2026.2746891","url":null,"abstract":"<p><p>The longevity <i>in vitro</i> of viability and motility of spermatozoa from a single ejaculate is seldom studied. The physiological decay of human sperm under room temperature <i>in vitro</i> remains a critical yet under-explored area. While standard clinical procedures typically involve short-term sperm handling, the development of novel techniques demands a deeper understanding of 'shelf-life' of sperm. This pilot study aimed to characterise human sperm longevity at room temperature by longitudinally assessing motility, viability and DNA fragmentation, and to evaluate whether culture medium replacement could extend <i>in vitro</i> sperm motility. Twenty-six semen samples with sperm concentration ≥ 15 million/ml and motility ≥ 40% were collected and motile sperm were concentrated using discontinuous gradient centrifugation. A subset of 20 samples was evaluated to determine the longitudinal dynamics of motility and viability. To establish the temporal profile of DNA damage, processed samples were collected using the swim-up method at Days 0, 3, 6, 9 and 12. The remaining 6 samples were used for motility parameter observations using computer-assisted semen analysis both with and without culture medium replacement. Following initial processing, the samples exhibited a baseline motility of 91.2 ± 3.4% and viability of 94.6 ± 3.5%. During 20-day incubation, sperm motility and viability declined in a time-dependent manner, with motility decreasing more rapidly than viability. Motility persisted for an average of 13.4 days. The 20 samples showed viability of 13.4 ± 4.4% at D20. In 10 samples that were fully observed for viability, the longevity range being 35-50 days. The D3 (2.4 ± 1.4%) and D6 (5.7 ± 5.8%) DNA fragmentation levels of progressively motile sperm showed no differences with D0 levels (3.9 ± 2.8%), but at later time points, progressively motile sperm showed increased DNA fragmentation, reaching 9% at D9 (p = 0.003) and 11.2% at D12 (p = 0.01). Additionally, processed sperm exposed to regular culture medium replacement showed prolonged longevity in regard to motility. In this pilot study, after routine processing <i>in vitro</i> and left at room temperature, human sperm had a motility longevity of between 8 and 18 days and a viability longevity of between 35 and 50 days, although after D9 progressively motile sperm displayed significantly increased DNA damage. Regular replacement of culture medium could support and prolong sperm motility longevity.</p>","PeriodicalId":13006,"journal":{"name":"Human Fertility","volume":"29 1","pages":"2746891"},"PeriodicalIF":2.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149266598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Human FertilityPub Date : 2026-12-01Epub Date: 2026-07-25DOI: 10.1080/14647273.2026.2708222
Penny Chamberlain, Vasanti Jadva, Suzanne Buckley
{"title":"Being a solo mother without the involvement of a partner: an exploration of parenting experiences and support needs.","authors":"Penny Chamberlain, Vasanti Jadva, Suzanne Buckley","doi":"10.1080/14647273.2026.2708222","DOIUrl":"https://doi.org/10.1080/14647273.2026.2708222","url":null,"abstract":"<p><p>An increasingly common family type, often referred to as 'solo mothers', 'single mothers by choice' or 'choice mothers', comprises women who intentionally become mothers without the involvement of a partner. Although solo mothers are often described as self-determined, motivated and well prepared for parenting, with both economic and social resources, little is known about their parenting experiences and emotional and practical support needs. This cross-sectional exploratory study used an online survey to examine sources of emotional and practical parenting support, ease of asking for help and parenting confidence. A total of 139 participants responded between July 2021 and February 2022. The most used sources of support were family networks and friendship groups of non-solo mothers. Paid childcare was also frequently used, with many solo mothers accessing it at least a few times per week. While most participants felt confident in their parenting, many occasionally struggled to ask for help and required additional practical, emotional and/or financial support. Positive correlations were found between feeling supported and parenting confidence (<i>r</i> = 0.405, <i>p</i> < 0.001) and between ease of asking for help and feeling supported (<i>r</i> = 0.458, <i>p</i> < 0.001). Greater efforts are needed to ensure solo mothers have equitable access to tailored emotional and practical support resources.</p>","PeriodicalId":13006,"journal":{"name":"Human Fertility","volume":"29 1","pages":"2708222"},"PeriodicalIF":2.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148590918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Human FertilityPub Date : 2026-12-01Epub Date: 2026-04-27DOI: 10.1080/14647273.2026.2639020
Sarah Martins da Silva, Helen Clarke, Marta Jansa Perez, Nicola E Mackie, Tristan J Barber, Jackson C Kirkman-Brown
{"title":"UK guidelines for the medical and laboratory procurement and use of sperm, egg and embryo donors (2025)*,*.","authors":"Sarah Martins da Silva, Helen Clarke, Marta Jansa Perez, Nicola E Mackie, Tristan J Barber, Jackson C Kirkman-Brown","doi":"10.1080/14647273.2026.2639020","DOIUrl":"10.1080/14647273.2026.2639020","url":null,"abstract":"<p><p>These guidelines replace the previous (2019) UK guidelines for the medical and laboratory screening of sperm, egg and embryo donors and were achieved by a joint working group composed of representatives from the Association of Reproductive and Clinical Scientists (ARCS), the British Fertility Society (BFS), the British Association for Sexual Health and HIV (BASHH) and the British HIV Association (BHIVA), with review and comments from their respective memberships. It was written to guide best practice in clinics but is not intended as a tool to judge the practice of centres within the UK or beyond. Guidance on core information that should be supplied to all parties involved in donation is provided. Screening tests and standards required are summarised, as are specific considerations for known donation and embryo donation. The assessment of genetic risk and heritable disorders has been fundamentally reviewed in light of technological advances. Extended carrier screening is also discussed, although we do not suggest that this is routinely performed.</p>","PeriodicalId":13006,"journal":{"name":"Human Fertility","volume":"29 1","pages":"2639020"},"PeriodicalIF":2.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147769907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Human FertilityPub Date : 2026-12-01Epub Date: 2026-07-02DOI: 10.1080/14647273.2026.2691185
Sophie Walter, Shiao Chan, Naimah Raza, Rima K Dhillon-Smith
{"title":"Investigating the effect of preconception untreated subclinical hypothyroidism (TSH above normal range and below 6.0 mIU/L) on assisted reproductive technology (ART) outcomes.","authors":"Sophie Walter, Shiao Chan, Naimah Raza, Rima K Dhillon-Smith","doi":"10.1080/14647273.2026.2691185","DOIUrl":"https://doi.org/10.1080/14647273.2026.2691185","url":null,"abstract":"<p><p>Subclinical hypothyroidism (SCH) is a biochemical diagnosis with ongoing uncertainty regarding management in reproductive medicine. We performed a retrospective cohort study evaluating fertility and pregnancy outcomes in women undergoing assisted reproductive technology (ART), focusing on untreated preconception SCH with TSH up to 6.0mIU/L. Secondary analysis used data from women screened for thyroid function and thyroid peroxidase antibodies (TPOAb) during the TABLET trial at Birmingham Women's Hospital, UK (June 2012-December 2013). Women with TSH ≥6.0mIU/L received levothyroxine. The primary outcome was live birth. The main comparison was 'total SCH' (TSH >3.63mIU/L) versus 'euthyroid-1' (TSH 0.44-3.63mIU/L), with subgroup analyses comparing 'untreated SCH' (TSH 3.64-5.99mIU/L) to 'euthyroid-1' women, and a stricter euthyroid threshold ('euthyroid-2'; TSH 0.44-2.5mIU/L) versus 'untreated high-normal-mild SCH' (TSH 2.5-5.99mIU/L). Multivariable logistic regression adjusted for key confounders. Of 944 women screened, 560 had outcome data; 60 had SCH. SCH was associated with fewer oocytes retrieved (9.0 vs 10.4, p = 0.02) and mature oocytes (7.4 vs 8.4, p = 0.05), but no difference in live birth was seen across comparisons: 'untreated SCH' vs euthyroid-1 (aOR 1.01, 95% CI 0.54-1.87, p = 1.0) and 'untreated high-normal-mild-SCH' vs euthyroid-2 (aOR 0.96, 95% CI 0.65-1.42, p = 0.8). In women with untreated SCH achieving live birth, TSH normalised spontaneously in 8/15 cases, with no adverse outcomes observed. Untreated TSH <6.0 mIU/L does not appear to adversely affect ART or live birth outcomes, although larger prospective studies are needed.</p>","PeriodicalId":13006,"journal":{"name":"Human Fertility","volume":"29 1","pages":"2691185"},"PeriodicalIF":2.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148375285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Human FertilityPub Date : 2026-12-01Epub Date: 2026-09-22DOI: 10.1080/14647273.2026.2731720
{"title":"Retraction Statement: The effects of autologous platelet-rich plasma in repeated implantation failure: a randomized controlled trial.","authors":"","doi":"10.1080/14647273.2026.2731720","DOIUrl":"https://doi.org/10.1080/14647273.2026.2731720","url":null,"abstract":"","PeriodicalId":13006,"journal":{"name":"Human Fertility","volume":"29 1","pages":"2731720"},"PeriodicalIF":2.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149016658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Human FertilityPub Date : 2026-12-01Epub Date: 2026-02-01DOI: 10.1080/14647273.2025.2595800
Sonja Goedeke, Astrid Indekeu, Marilyn Crawshaw
{"title":"Donor conception and psychosocial support provisions across jurisdictions - what's out there?","authors":"Sonja Goedeke, Astrid Indekeu, Marilyn Crawshaw","doi":"10.1080/14647273.2025.2595800","DOIUrl":"10.1080/14647273.2025.2595800","url":null,"abstract":"<p><p>As demand for donor conception (DC) rises the landscape is becoming increasingly complex. DC-linking now occurs through various means, including direct-to-consumer DNA testing, which may reveal DC where this has not been disclosed and make those genetically related known to each other, including earlier than is possible through identity-release provisions in many jurisdictions. Early contact between donors and recipient parents, as well as same-donor siblings is becoming more common. Large sibling groups within and across jurisdictions are increasingly being identified and there is also growing reliance on imported gametes and online donor recruitment platforms. These developments can be associated with challenges for donor-conceived people (DCP), parents, donors and their families, and have led to calls for more accessible and responsive psycho-social support services. This paper maps the DC context in ten Western countries, including the availability of psychosocial support and counselling. Given the growing complexity of DC and its lifelong impact on all involved, we pay particular attention to post-donation counselling support related to disclosure, long-term psychosocial wellbeing, and DC-linking. We identify key challenges in existing DC provisions and support systems and propose improvements that support DCP, donors, parents, siblings, and their families in managing the longer-term implications of DC.</p>","PeriodicalId":13006,"journal":{"name":"Human Fertility","volume":"29 1","pages":"2595800"},"PeriodicalIF":2.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146099739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The global evaluation of the effects of antioxidants on seminal outcomes in infertile men: a systematic review and meta-analysis.","authors":"Qinyan Xu, Zhongying Wan, Zhiyuan Xiong, Xiaoyun Zhu, Qin Han, Yiya Wang, Jiayu Zhao, Feihu Yu","doi":"10.1080/14647273.2026.2650222","DOIUrl":"10.1080/14647273.2026.2650222","url":null,"abstract":"<p><p>The aim of the current review is to summarise information from publications on the impact of antioxidants on seminal outcomes in infertile men. A systematic search was performed in the five valid databases (Scopus, PubMed, Medline, Embase, and Web of Science) utilizing two sets of keywords up to September 2025, according to the PRISMA approach. Of the 11749 papers identified, 101 papers were included in this review, for a total of 11889 infertile men. Sperm concentration, normal sperm morphology, progressive sperm motility, and total sperm motility, were considerably higher in experimental groups compared with control groups. Both sperm concentration (10<sup>6</sup> mL<sup>-1</sup>) and total motility (%) were higher in experimental groups compared to control groups with an overall pooled standardised mean difference (SMD) of 2.33 (95% CI: 1.73, 2.94) for sperm concentration and SMD of 1.62 (95% CI: 1.20, 2.04) for total motility (%). Subgroup analysis demonstrated that duration of treatments of more than 6 months were more effective than those of less than 3 months. Based on the findings of this review, no definitive recommendation can be made regarding the use of antioxidants as a therapy for male infertility, and further research is necessary.</p>","PeriodicalId":13006,"journal":{"name":"Human Fertility","volume":"29 1","pages":"2650222"},"PeriodicalIF":2.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147689451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The use of gametes from donors who have undergone expanded carrier screening: a guidance for UK practice.","authors":"Valerie Shaikly, Mariano Mascarenhas, Anneke Lucassen, Debra Bloor, Saffron Townsend Browne, Karen Thompson, Harish Bhandari","doi":"10.1080/14647273.2026.2733076","DOIUrl":"10.1080/14647273.2026.2733076","url":null,"abstract":"<p><p>Expanded carrier screening (ECS) is increasingly offered within assisted reproductive technologies (ART), particularly as a component of donor gamete selection. As genomic testing options rapidly evolve, the complexity of interpreting ECS results presents significant challenges for donor gamete recipients and the healthcare professionals supporting them. At the same time, regulatory frameworks and professional guidelines have not kept pace with these technological developments, resulting in gaps between clinical practice and formal guidance. This paper aims to summarise current practice, highlight emerging issues arising from the integration of ECS into gamete selection, and provide recommendations to facilitate informed decision-making.</p>","PeriodicalId":13006,"journal":{"name":"Human Fertility","volume":"29 1","pages":"2733076"},"PeriodicalIF":2.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149074493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}